Safety and dose modification for patients with low body weight receiving niraparib in the ENGOT-OV16/NOVA phase III trial
| Autor: | Lord, R., Mirza, M.R., Woelber, L., Lesoin, A., Pineda, M.J., Peen, U., Hazard, S.J., Matulonis, U.A. |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2018 149 Supplement 1:11-11 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect